Which GLP 1 Drugs Are Approved for Obesity

Reading time
26 min
Published on
July 2, 2025
Updated on
June 22, 2026
Which GLP 1 Drugs Are Approved for Obesity

Table of Contents

  1. Introduction
  2. Defining GLP-1 Receptor Agonists
  3. Which GLP 1 Drugs Are Approved for Obesity?
  4. The Distinction Between Weight Loss and Diabetes Approvals
  5. How GLP-1 Medications Facilitate Weight Loss
  6. Eligibility for Obesity-Approved Medications
  7. The Role of Compounded Medications
  8. Starting Your Weight Loss Journey with TrimRx
  9. Managing Potential Side Effects
  10. Support Beyond Medication
  11. Why Personalization Matters
  12. The Future of Obesity Treatment
  13. Conclusion
  14. FAQ

Introduction

Navigating the world of weight loss medications can feel like learning a second language. With new brand names appearing in the news daily, it is easy to feel overwhelmed by the difference between a medication meant for blood sugar and one meant for chronic weight management. You might be wondering why some people take one brand for diabetes while others take a nearly identical version for weight loss. At TrimRx, we believe that understanding the science behind these treatments is the first step toward reclaiming your health. This article explores the specific GLP-1 medications currently approved by the FDA for obesity, how they differ from diabetes treatments, and how a personalized telehealth program can help you find the right path for your unique biology.

Defining GLP-1 Receptor Agonists

Before identifying which specific medications are approved for weight management, it is important to understand what they actually are. GLP-1 stands for glucagon-like peptide-1. This is a hormone your body naturally produces in your intestines whenever you eat. Its primary job is to tell your brain you are full and to signal your pancreas to release insulin, which manages your blood sugar.

A GLP-1 receptor agonist is a type of medication designed to mimic this natural hormone. In medical terms, an “agonist” is a substance that attaches to a cell receptor and triggers the same action as the natural substance. Because these medications are more potent and last much longer in the body than the natural hormone, they can produce more significant effects on appetite and digestion.

Key Takeaway: GLP-1 medications work by mimicking a natural “fullness” hormone. They help regulate blood sugar, slow down how quickly your stomach empties, and signal to your brain that you have had enough to eat.

Which GLP 1 Drugs Are Approved for Obesity?

While many GLP-1 medications exist, the U.S. Food and Drug Administration (FDA) has specific criteria for approving a drug for “chronic weight management.” To receive this approval, a drug must undergo rigorous clinical trials specifically focused on its ability to help individuals lose weight and maintain that loss safely over time.

For a broader look at how these medications fit into treatment planning, see our guide on how to order GLP-1 medications effectively.

Currently, there are three primary GLP-1 (or dual-acting) medications with FDA approval for obesity:

Wegovy® (Semaglutide)

Wegovy® was approved by the FDA in 2021 for chronic weight management. The active ingredient is semaglutide, the same ingredient found in the diabetes medication Ozempic®. However, the version approved for obesity is administered at a higher maximum weekly dose. Clinical trials, known as the STEP trials, showed that semaglutide was highly effective for weight loss when combined with lifestyle changes.

Zepbound® (Tirzepatide)

Zepbound® is one of the newest and most potent entries into the weight loss category. Approved in late 2023, its active ingredient is tirzepatide. This medication is unique because it is a dual-agonist. It mimics GLP-1 and another hormone called GIP (glucose-dependent insulinotropic polypeptide). By targeting two different hormone pathways, it often yields even more significant weight loss results in clinical settings compared to single-agonist medications.

If you want to understand the science behind that dual action in more depth, read our explanation of Zepbound single dose vial basics.

Saxenda® (Liraglutide)

Saxenda® was one of the first GLP-1 medications approved for weight loss. The active ingredient is liraglutide. Unlike the newer weekly injections, this medication is typically administered once daily. While it is generally considered less potent than semaglutide or tirzepatide, it remains an important option for those who may not tolerate the newer medications or who prefer a daily dosing schedule.

The Distinction Between Weight Loss and Diabetes Approvals

One of the most common points of confusion is the difference between medications like Ozempic® and Wegovy®, or Mounjaro® and Zepbound®. While these pairs share the same active ingredients, they are not legally the same in the eyes of the FDA.

Active Ingredient Approved for Type 2 Diabetes Approved for Obesity/Weight Loss
Semaglutide Ozempic® (Injection), Rybelsus® (Oral) Wegovy® (Injection)
Tirzepatide Mounjaro® (Injection) Zepbound® (Injection)
Liraglutide Victoza® (Injection) Saxenda® (Injection)

Why the Different Names? Pharmaceutical companies often conduct separate clinical trials for different health conditions. A drug approved for Type 2 diabetes is intended to lower blood sugar (A1C). A drug approved for obesity is intended to reduce body mass. Because the dosages for weight loss are often higher than those used for diabetes, the FDA requires distinct brand names and labeling to ensure patient safety and proper usage.

How GLP-1 Medications Facilitate Weight Loss

It is a common misconception that these medications are simply “metabolism boosters.” In reality, they work through complex biological pathways that address the root causes of overeating and weight gain.

Satiety and the Brain The hypothalamus is the part of your brain that regulates hunger. GLP-1 medications bind to receptors in this area, effectively “quieting” what many patients describe as “food noise”—the constant, intrusive thoughts about eating. This makes it much easier to stick to a reduced-calorie diet because the brain genuinely feels satisfied.

Gastric Emptying These medications slow down the rate at which food moves from the stomach into the small intestine. This process, called delayed gastric emptying, ensures that you feel physically full for a longer duration after a meal. This mechanical effect works in tandem with the brain signaling to reduce overall calorie intake.

Insulin Regulation While weight loss is the primary goal for many, these medications also improve the body’s relationship with glucose. By signaling the pancreas to release insulin only when blood sugar is rising, they help stabilize energy levels and prevent the dramatic spikes and crashes that often lead to sugar cravings.

For a deeper dive into whether these medications are helping patients in real-world use, see our article on whether GLP-1 works.

Eligibility for Obesity-Approved Medications

The FDA does not approve these medications for “cosmetic” weight loss. They are intended for individuals who face health risks due to their weight. The standard eligibility criteria used by healthcare providers include:

  1. BMI of 30 or Greater: This is the clinical definition of obesity.
  2. BMI of 27 or Greater with Comorbidities: An individual may qualify with a lower Body Mass Index if they also suffer from a weight-related health condition. These conditions include:
    • High blood pressure (Hypertension)
    • Type 2 diabetes or Prediabetes
    • High cholesterol (Dyslipidemia)
    • Obstructive sleep apnea

Note: It is essential to consult with a licensed healthcare provider to determine if you meet these criteria. A medical professional will review your history, lab work, and current medications to ensure a GLP-1 program is safe for you.

The Role of Compounded Medications

Because medications like Wegovy® and Zepbound® have become so popular, there have been significant supply shortages. During these times, some patients turn to compounded semaglutide or compounded tirzepatide.

It is vital to understand the distinction: compounded medications are not FDA-approved. While the brand-name drugs mentioned earlier have gone through the full FDA approval process for weight loss, compounded versions are “custom-mixed” by specialized pharmacies.

At TrimRx, we only work with FDA-registered and inspected compounding pharmacies. This ensures that the medication is prepared in facilities that meet strict federal standards for safety and quality. Compounded options can provide an accessible alternative when branded medications are in short supply or otherwise unavailable, but they should always be sourced through a reputable platform that prioritizes clinical oversight.

Starting Your Weight Loss Journey with TrimRx

We understand that the traditional medical system can make accessing these treatments difficult. Between long wait times for specialists and the confusion of pharmacy stock, many people feel stuck before they even begin.

Our platform was designed to remove these barriers. We provide a telehealth-first approach that connects you with licensed providers who specialize in metabolic health. When you use our service, you are not just getting a prescription; you are getting a personalized program tailored to your body’s needs.

The TrimRx Process:

  • Step 1: The Assessment. You begin by completing a free health assessment quiz that covers your medical history and weight loss goals.
  • Step 2: Provider Review. A licensed clinician reviews your information and determines if a GLP-1 medication is appropriate for you.
  • Step 3: Personalized Treatment. If eligible, your provider will design a program, which may include compounded medications shipped directly to your door from our partner pharmacies.
  • Step 4: Ongoing Support. Our team remains available to you 24/7 to help manage side effects and adjust your program as you progress.

Managing Potential Side Effects

While GLP-1 medications are transformative for many, they are not without side effects. Because they slow down the digestive system, most common issues are gastrointestinal in nature.

Common Side Effects Include:

  • Nausea: Usually most noticeable when first starting or increasing a dose.
  • Vomiting: Often occurs if meals are too large or high in fat.
  • Diarrhea or Constipation: Changes in digestion speed can affect bowel habits.
  • Stomach Pain: General discomfort as the body adjusts to the medication.

Bottom line: Most side effects are mild to moderate and tend to decrease over time as your body acclimates to the medication. Following a provider’s guidance on dosing and dietary choices is the best way to minimize discomfort.

Support Beyond Medication

Successful weight management is rarely about a “silver bullet.” Even the most effective FDA-approved medications work best when supported by a healthy foundation. At TrimRx, we encourage a holistic view of health that includes nutrient support and lifestyle changes.

For those looking to optimize their results, we offer quick-access supplements like GLP-1 Daily Support.

We also offer Weight Loss Boost for additional metabolic support during your weight loss journey.

Why Personalization Matters

The reason one person loses weight quickly on semaglutide while another may find better success with tirzepatide comes down to individual biology. Genetics, hormonal balance, and lifestyle all play a role in how your body responds to a GLP-1 receptor agonist.

This is why we focus on personalized programs. Rather than a one-size-fits-all approach, our platform allows for adjustments based on your real-world experience. If you find the side effects of one dose too high, or the results of another too slow, your medical team is there to pivot your strategy. This level of care ensures that your journey is not only effective but also sustainable for the long term.

If you want a practical look at how people are using tirzepatide over time, our guide to tirzepatide 6 month weight loss may help.

The Future of Obesity Treatment

The medical community’s understanding of obesity has shifted. It is no longer viewed as a simple lack of willpower, but as a complex, chronic metabolic condition. The approval of GLP-1 drugs specifically for obesity marks a major milestone in giving people the tools they need to manage this condition effectively.

As research continues, we expect to see even more medications enter the market, offering even more specific ways to target hunger and metabolism. By staying informed about which drugs are approved and how they work, you are empowering yourself to make the best decisions for your future.

Conclusion

Understanding which GLP 1 drugs are approved for obesity is the first step toward a more informed and successful weight loss journey. By choosing a path that combines FDA-backed science with clinical oversight, you can address the biological roots of weight management. Our mission at TrimRx is to provide a bridge between these advanced treatments and the personalized, empathetic care you deserve. Whether you are just beginning to research or are ready to take the next step, we are here to guide you toward a healthier version of yourself.

Next Steps: If you are ready to see if an FDA-approved GLP-1 medication or a personalized compounded program is right for you, take our free health assessment quiz today. It is a simple, no-pressure way to start your conversation with a healthcare professional.

FAQ

Is Ozempic approved for weight loss?

No, Ozempic® is technically FDA-approved only for the treatment of Type 2 diabetes. However, its active ingredient, semaglutide, is approved for weight loss under the brand name Wegovy®. Many doctors may prescribe Ozempic® “off-label” for weight management, but Wegovy® is the version specifically labeled for that purpose.

What is the difference between Wegovy and Zepbound?

Wegovy® contains semaglutide and targets only the GLP-1 hormone receptor. Zepbound® contains tirzepatide and is a dual-agonist, targeting both GLP-1 and GIP receptors. In clinical trials, Zepbound® generally showed slightly higher percentages of weight loss, though both are considered highly effective for obesity management.

Do I have to have diabetes to take a GLP-1 drug for obesity?

No, you do not need a diabetes diagnosis to be eligible for GLP-1 medications that are FDA-approved for weight management, such as Wegovy® or Zepbound®. These drugs are specifically indicated for individuals with obesity (BMI ≥ 30) or those who are overweight (BMI ≥ 27) with a weight-related health condition.

Can I get these medications through telehealth?

Yes, you can access GLP-1 treatments through telehealth platforms like ours. A licensed healthcare provider will conduct a virtual assessment of your health history and goals to determine if you are a candidate for the program. If approved, your treatment plan and medication can be managed entirely online without the need for in-person office visits.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.

Transforming Lives, One Step at a Time

Patients on TrimRx can maintain the WEIGHT OFF
Start Your Treatment Now!

Keep reading

GLP
4 min read

Mons Pubis Fat Loss on GLP-1s: The “Pubic Area” Change Nobody Mentions

One change that surprises people on GLP-1 medications rarely comes up in conversation: the mons pubis, the soft fat pad over the pubic bone,…

GLP
13 min read

How to Adjust Weight Loss Goals on GLP-1 Medications

Adjust weight goals on GLP-1 meds by tracking body composition and labs, optimizing protein, activity, sleep, and working with your provider on dosing.

GLP
3 min read

Falsified Mounjaro pens prompt urgent safety advisory

MHRA warns of counterfeit Mounjaro pens (batch D873576); stop use and check batch numbers for infection risk.

Stay on Track

Join our community and receive:
Expert tips on maximizing your GLP-1 treatment.
Exclusive discounts on your next order.
Updates on the latest weight-loss breakthroughs.